Crescent Capital BDC, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Crescent Capital BDC, Inc. (CCAP) on February 6, 2020, covering events as of January 31, 2020. The filing details a stock repurchase program implemented in connection with the company's acquisition of Alcentra Capital Corporation.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The primary financial metric disclosed is the authorization for a stock repurchase program with an aggregate commitment of up to $20 million.
Material Changes and Program Details
- Repurchase Authorization: Crescent BDC committed to repurchase up to $20 million of its outstanding common stock.
- Start Date: Repurchases are scheduled to begin on March 2, 2020, subject to trading price conditions.
- Pricing Condition: Purchases may occur only when the market price is 10% or more below the "Combined NAV."
- Combined NAV Definition: Defined as the estimated pro forma combined NAV (until a post-February 1, 2020 NAV is announced) or the most recently announced NAV thereafter. If a range is provided, the highest NAV in the range is used.
- Employee Participation: A separate employee purchase program is expected to exceed $3 million. These purchases will count toward and reduce the $20 million company commitment dollar-for-dollar.
Guidance, Outlook, and Risks
The filing does not contain forward-looking financial guidance or management commentary regarding future earnings. The repurchase program is subject to conditions and must be conducted in accordance with Rule 10b-18 under the Securities Exchange Act of 1934, which imposes restrictions on the method, timing, price, and volume of stock repurchases.
Key Facts for Investor Verification
- Verify the current trading price of CCAP relative to the most recently announced Combined NAV to determine if the 10% discount threshold for repurchases is met.
- Monitor the actual volume of shares repurchased starting March 2, 2020, to assess the utilization of the $20 million authorization.
- Confirm the final pro forma Combined NAV once announced to understand the specific price floor for the buyback program.
- Track the separate employee purchase program to understand the net amount remaining for open market repurchases by the company.